NCT03082183View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

June 20, 2017

Study Completion Date

June 20, 2017

Conditions
Healthy
Interventions
DRUG

Rifampicin

once daily

DRUG

BI 425809

once daily

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY